HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Matthias Fischer Selected Research

N-Myc Proto-Oncogene Protein

12/2019A Novel MYCN-Specific Antigene Oligonucleotide Deregulates Mitochondria and Inhibits Tumor Growth in MYCN-Amplified Neuroblastoma.
11/2019The long noncoding RNA lncNB1 promotes tumorigenesis by interacting with ribosomal protein RPL35.
11/2019Drugging MYCN Oncogenic Signaling through the MYCN-PA2G4 Binding Interface.
11/2012LIN28B induces neuroblastoma and enhances MYCN levels via let-7 suppression.
5/2010Transcriptional repression of SKP2 is impaired in MYCN-amplified neuroblastoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Matthias Fischer Research Topics

Disease

79Neuroblastoma
10/2022 - 07/2004
55Neoplasms (Cancer)
10/2022 - 07/2004
17Out-of-Hospital Cardiac Arrest
12/2022 - 01/2007
15Heart Arrest (Cardiac Arrest)
12/2022 - 09/2002
6Wounds and Injuries (Trauma)
12/2020 - 04/2007
4Anaphylaxis (Anaphylactic Shock)
01/2021 - 01/2018
4Hypoxia (Hypoxemia)
12/2020 - 07/2011
4Carcinogenesis
11/2019 - 01/2009
4Ventricular Fibrillation
10/2004 - 09/2002
3Hemorrhage
12/2020 - 02/2009
2Rhabdomyosarcoma
12/2021 - 01/2016
2Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
12/2021 - 01/2016
2Psoriasis (Pustulosis Palmaris et Plantaris)
02/2021 - 09/2004
2Parakeratosis
02/2021 - 09/2004
2Cardiovascular Diseases (Cardiovascular Disease)
12/2020 - 05/2019
2Acute Coronary Syndrome
10/2019 - 03/2014
2Body Weight (Weight, Body)
11/2017 - 01/2007
2Disease Progression
10/2017 - 10/2015
2Cardiogenic Shock
03/2016 - 03/2014
2Skin Diseases (Skin Disease)
02/2009 - 09/2004
1Chromothripsis
12/2021
1Pityriasis Lichenoides (Pityriasis Lichenoides et Varioliformis Acuta)
02/2021
1Leukoplakia
02/2021
1Blepharitis
02/2021
1Birdshot Chorioretinopathy
02/2021
1Uveitis
02/2021
1Corneal Perforation
02/2021
1Atrophy
02/2021
1Ichthyosis (Xeroderma)
02/2021
1Trichiasis
02/2021
1Pityriasis Rubra Pilaris
02/2021
1Entropion
02/2021
1Ectropion
02/2021
1Dyskeratosis Congenita (X-Linked Dyskeratosis Congenita)
02/2021
1Keratitis
02/2021
1Darier Disease (Darier's Disease)
02/2021
1Retinal Neovascularization
02/2021
1Conjunctivitis
02/2021
1Scleritis (Episcleritis)
02/2021
1Pachyonychia Congenita (Jadassohn-Lewandowsky Syndrome)
02/2021
1Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder)
01/2021
1Asthma (Bronchial Asthma)
01/2021
1Hypersensitivity (Allergy)
01/2021

Drug/Important Bio-Agent (IBA)

11Messenger RNA (mRNA)IBA
04/2022 - 02/2005
11Pharmaceutical PreparationsIBA
01/2020 - 01/2009
10Proteins (Proteins, Gene)FDA Link
01/2022 - 08/2007
9DNA (Deoxyribonucleic Acid)IBA
12/2021 - 12/2014
7Telomerase (Telomerase Reverse Transcriptase)IBA
01/2021 - 10/2012
7Biological ProductsIBA
11/2019 - 02/2005
6Long Noncoding RNAIBA
01/2021 - 11/2014
6Biomarkers (Surrogate Marker)IBA
12/2019 - 11/2014
5Tretinoin (Retinoic Acid)FDA LinkGeneric
04/2022 - 04/2011
5RNA (Ribonucleic Acid)IBA
01/2021 - 07/2009
5N-Myc Proto-Oncogene ProteinIBA
12/2019 - 05/2010
5OligonucleotidesIBA
12/2019 - 11/2006
4Anaplastic Lymphoma KinaseIBA
10/2022 - 08/2011
4Epinephrine (Adrenaline)FDA LinkGeneric
01/2019 - 01/2007
4ChromatinIBA
01/2019 - 10/2008
4MicroRNAs (MicroRNA)IBA
12/2018 - 11/2012
3Histone Deacetylase InhibitorsIBA
01/2019 - 01/2009
3Complementary DNA (cDNA)IBA
12/2007 - 01/2006
2MYCN inhibitor BGA002IBA
04/2022 - 12/2019
2Transcription Factors (Transcription Factor)IBA
01/2022 - 02/2016
2ChemokinesIBA
01/2021 - 01/2017
2InterferonsIBA
01/2021 - 01/2017
2Cell-Free Nucleic AcidsIBA
11/2020 - 10/2017
2Circular DNAIBA
04/2020 - 01/2020
2Adrenergic Agents (Adrenergic Drugs)IBA
01/2020 - 11/2012
2Oncogene Proteins (Oncogene Protein)IBA
11/2019 - 11/2019
2HomocysteineIBA
11/2017 - 03/2006
2BI 2536IBA
01/2017 - 02/2011
2Polo-Like Kinase 1IBA
01/2017 - 02/2011
2Histone Deacetylases (Histone Deacetylase)IBA
01/2017 - 01/2009
2DecitabineFDA Link
02/2016 - 12/2014
2AutoantibodiesIBA
01/2016 - 07/2012
2Folic Acid (Vitamin M)FDA LinkGeneric
06/2015 - 03/2006
2AntigensIBA
07/2012 - 07/2004
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
10/2022
1Cystine (L-Cystine)IBA
01/2022
1Cysteine (L-Cysteine)FDA Link
01/2022
1ceritinibIBA
12/2021
1NucleotidesIBA
07/2021
1Retinaldehyde (Retinal)IBA
02/2021
1carfilzomibIBA
01/2021
1OTX015IBA
01/2021
1ProteomeIBA
01/2021
1Proteasome InhibitorsIBA
01/2021
14'-N,N-dimethylamino-4-aminoazobenzeneIBA
01/2021
1Recombinant ProteinsIBA
01/2021

Therapy/Procedure

32Therapeutics
10/2022 - 10/2004
19Cardiopulmonary Resuscitation (CPR)
12/2022 - 09/2002
18Resuscitation
12/2022 - 04/2007
4Drug Therapy (Chemotherapy)
01/2019 - 04/2015
3Extracorporeal Membrane Oxygenation
03/2016 - 03/2014
3Percutaneous Coronary Intervention
03/2014 - 05/2010
2Investigational Therapies (Experimental Therapy)
10/2021 - 01/2020
2Critical Care (Surgical Intensive Care)
01/2021 - 02/2009
2Airway Management
01/2020 - 06/2015
2Combined Modality Therapy
10/2016 - 10/2015
2Microspheres (Microsphere)
03/2003 - 09/2002